LabCorp in talks to buy PPD for $8Bn

By Dani Bancroft contact

- Last updated on GMT

LabCorp in talks to buy the CRO PPD for $8Bn

Related tags: Laboratory, United states, North carolina

Unconfirmed reports suggest Laboratory Corporation of America Holdings (LabCorp) is in talks to acquire contract research organization Pharmaceutical Product Development LLC (PPD).

According to a Reuters report​, a second party is taking part in the auction of PPD with LabCorp, but has not yet been identified​. 

If LabCorp was to acquire PPD, the transaction's value would exceed the $5.7bn for which it purchased Covance​ in 2015.

PPD offers contract research services from inhalation products to biologics​, for a wide range of indications, with headquarters in Wilmington, North Carolina. 

The firm has more than 18,500 employees worldwide and is owned by Carlyle Group LP and Hellman & Friedman LLC, which made the company private in 2011 for $3.9bn.

LabCorp is a North Carolina, US-based clinical lab network with a $14.3bn (€13.3bn) market cap. Last month, it acquired​ Mount Sinai’s clinical outreach laboratories, adding seven patient service centers to its network.

Related news

Show more

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Stability Testing As a Quality Control Measure

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Related suppliers

Follow us

Products

View more

Webinars